Dear Colleagues in ESP Advisory Board and elsewhere, 

I’m trying to help Prof. Christine Desmedt, who leads a large research and clinical study aiming at better characterization of lobular breast cancer.

Prof. Desmedt – on behalf of the European Lobular Breast Cancer Consortium (ELBCC, and the COST Action LOBSTERPOT (#19138) she coordinates with Patrick Dersken (Utrecht, The Netherlands) and Anne Salomon (Curie, Paris) – would like to ask all those colleagues to partake who are willing to contribute to a survey that takes only a few minutes. 
I quote below her words:

“One of the goals of our consortium, and in particular of the pathology working group, lead by Prof. Dr. Anne Salomon and Prof. Dr. Matthias Christgen, is to have harmonized pathological diagnosis guidelines for invasive lobular breast cancer (ILC) in the world. The starting point here is to evaluate and report how ILC is currently diagnosed in the world.

To gather this information, we need pathologists from all over the world to take 5 to 10 minutes of their time to fill in the following survey before June 7

(Importantly, we advise the pathologists to first check their antibody clones and staining conditions for e-cadherin and the catenins before filling in the questionnaire.)

We plan to publish the results of the survey in a pathology journal, and we would list all the pathologists that filled in this survey in the acknowledgment section. Importantly, if they want their name and affiliation to appear there, they should leave their contact details at the end of the survey.”

Please spread the word among your colleagues.

Thanking you in advance for your contribution and help, and wishing you a good weekend,

Best regards,

Janina Kulka MD PhD

DScSemmelweis University Budapest

2nd Department of Pathology